相关实验视频
Updated: Jul 16, 2026
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
黑色素瘤生物学和新的向疗法
Vanessa Gray-Schopfer1, Claudia Wellbrock, Richard Marais
1The Institute of Cancer Research, Signal Transduction Team, Cancer Research UK Centre of Cell and Molecular Biology, 237 Fulham Road, London SW3 6JB, UK.
Nature
|February 23, 2007
概括
黑色素瘤是一种来自色素细胞的皮肤癌,在全球范围内正在增加. 新的细胞信号洞察力正在推动针对这种难以治疗的疾病的向治疗.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 细胞生物学 细胞生物学
背景情况:
- 黑色素瘤起源于黑色素细胞,皮肤的专业色素细胞.
- 全球黑色素瘤发病率正在上升,在过去二十年中,西方人口的发病率翻了一番.
- 早期的黑色素瘤是通过手术治愈的,但转移性黑色素瘤是抗治疗的.
研究的目的:
- 为突出了解黑色素瘤生物学方面的最新进展.
- 根据新发现,讨论开发有针对性的药物和新疗法.
- 为了应对治疗晚期黑色素瘤的挑战.
主要方法:
- 审查最近发现的黑色素瘤细胞信号通路.
- 分析新兴的有针对性的药物开发战略.
- 探索黑色素瘤的新治疗方法.
主要成果:
- 对导致黑色素瘤的分子机制有了更深入的了解.
- 确定关键的细胞信号通路对于黑色素瘤进展至关重要.
- 开发针对特定黑色素瘤弱点的新型治疗策略.
结论:
- 细胞信号研究的进展对于对抗黑色素瘤至关重要.
- 向治疗为治疗晚期黑色素瘤提供了新的希望.
- 对黑色素瘤生物学的持续研究对于改善患者的治疗结果至关重要.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...